title: Biopharmaceuticals and gene vectors opening new avenues in cancer immune therapy.
authors.affiliation: MMCT Laboratory of Macromolecular Cancer Therapeutics, Department for Pharmaceutical Chemistry, Faculty Center for Pharmacy, University of Vienna, Althanstraß e 14, A-1090 Vienna, Austria.
authors.forename: Haider
authors.initials: H
authors.lastname: Sami
authors.affiliation: MMCT Laboratory of Macromolecular Cancer Therapeutics, Department for Pharmaceutical Chemistry, Faculty Center for Pharmacy, University of Vienna, Althanstraß e 14, A-1090 Vienna, Austria.
authors.forename: Manfred
authors.initials: M
authors.lastname: Ogris
mesh_terms: D000818:Animals; D001688:Biological Products / Q000008:administration & dosage / Q000276:immunology*; D001702:Biopharmaceutics; D015316:Genetic Therapy / Q000639:trends*; D005822:Genetic Vectors / Q000008:administration & dosage / Q000235:genetics / Q000276:immunology*; D006801:Humans; D007167:Immunotherapy / Q000639:trends*; D009369:Neoplasms / Q000235:genetics / Q000276:immunology* / Q000628:therapy; D050130:Oncolytic Virotherapy / Q000639:trends
chemical_list: D001688:Biological Products
keywords: cancer; cancer gene therapy; immune checkpoint inhibitors; oncolytic virus